 Dexamethasone therapy neonatal chronic lung disease international placebo-controlled trial Collaborative Dexamethasone Trial Group multicenter trial steroid therapy chronic neonatal oxygen dependence neonates weeks age Active treatment duration ventilation infants ventilator dependent entry median days survivors vs significant differences total groups survivors time supplemental oxygen length stay hospital trend dexamethasone group Twenty-five infants group discharge ventilator dependent trial entry Open treatment steroids active group placebo group evidence serious side effects particular infection rates similar groups